Empagliflozin

Empagliflozin Benefits on Kidney Disease Progression, Death Continue for 1 Year Post-Discontinuation

admin November 4, 2024 0

Will Herrington, MA, MBBS, MD, FRCP, FERACredit: Oxford UniversityPost-trial follow-up (PTFU) of the EMPA-KIDNEY trial has revealed that empagliflozin continues...

Empagliflozin preserves kidney function in heart attack patients

Empagliflozin Benefits on Kidney Disease Progression, Death Continue for 1 Year Post-Discontinuation

Bone and Joint Health Supplements Market Size to Hit USD 9.40 Bn by 2035

Mass cancellations of orthopedic surgeries likely within weeks over compensation dispute, doctors say

N.W.T. leaders say Ottawa is underfunding Indigenous health-care program by millions

Istios Health Expands Into Nephrology With Three Practice Partnerships

Could dentists help Europe beat cervical cancer?

Empagliflozin preserves kidney function in heart attack patients

Empagliflozin Benefits on Kidney Disease Progression, Death Continue for 1 Year Post-Discontinuation

You may have missed

Bone and Joint Health Supplements Market Size to Hit USD 9.40 Bn by 2035

Mass cancellations of orthopedic surgeries likely within weeks over compensation dispute, doctors say

N.W.T. leaders say Ottawa is underfunding Indigenous health-care program by millions

Istios Health Expands Into Nephrology With Three Practice Partnerships

Could dentists help Europe beat cervical cancer?